Search research articles
Contact Us
Filters
Showing results (61-70 of 117) with videos related to
Page
of 12
Sort By:
Palliative & Supportive Care
|
April 6, 2006
Difficulties in screening for adjustment disorder, Part I: Use of existing screening instruments in cancer patients undergoing bone marrow transplantation
Kenneth L Kirsh, John H McGrew, Michael Dugan, et al.
The Clinical Journal of Pain
|
January 24, 2006
Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse
Steven D Passik, Kenneth L Kirsh, Kathleen B Donaghy, et al.
Journal of Addiction Medicine
|
September 21, 2016
Definitive LC-MS/MS Drug Monitoring Impacts Substance-use Treatment Planning and Patient Outcomes: A Brief Report
Adam Rzetelny, Barbara Zeller, Nicholas Miller, et al.
Journal of Pain and Symptom Management
|
March 5, 2003
An unsuccessful attempt to develop a single-item screen for insomnia in cancer patients
Steven D Passik, Laurie A Whitcomb, Kenneth L Kirsh, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
June 28, 2006
Brief report: pain and readiness to quit smoking cigarettes
Ellen J Hahn, Mary Kay Rayens, Kenneth L Kirsh, et al.
Journal of Behavioral Medicine
|
September 13, 2012
Attentional bias for prescription opioid cues among opioid dependent chronic pain patients
Eric L Garland, Brett E Froeliger, Steven D Passik, et al.
Journal of Opioid Management
|
March 10, 2015
Specimen validity testing in urine drug monitoring of medications and illicit drugs: clinical implications
Kenneth L Kirsh, Paul J Christo, Howard Heit, et al.
Palliative & Supportive Care
|
April 6, 2006
An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients
Dale E Theobald, Kenneth L Kirsh, Elizabeth Holtsclaw, et al.
Journal of Pain and Symptom Management
|
May 15, 2002
An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms
Dale E Theobald, Kenneth L Kirsh, Elizabeth Holtsclaw, et al.
Journal of Addiction Medicine
|
September 4, 2015
A Survey of ASAM Members' Knowledge, Attitudes, and Practices in Urine Drug Testing
Kenneth L Kirsh, Louis E Baxter, Adam Rzetelny, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 117) with videos related to
Sort By:
Page
of 12
Palliative & Supportive Care
|
April 6, 2006
Difficulties in screening for adjustment disorder, Part I: Use of existing screening instruments in cancer patients undergoing bone marrow transplantation
Kenneth L Kirsh, John H McGrew, Michael Dugan, et al.
The Clinical Journal of Pain
|
January 24, 2006
Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse
Steven D Passik, Kenneth L Kirsh, Kathleen B Donaghy, et al.
Journal of Addiction Medicine
|
September 21, 2016
Definitive LC-MS/MS Drug Monitoring Impacts Substance-use Treatment Planning and Patient Outcomes: A Brief Report
Adam Rzetelny, Barbara Zeller, Nicholas Miller, et al.
Journal of Pain and Symptom Management
|
March 5, 2003
An unsuccessful attempt to develop a single-item screen for insomnia in cancer patients
Steven D Passik, Laurie A Whitcomb, Kenneth L Kirsh, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
June 28, 2006
Brief report: pain and readiness to quit smoking cigarettes
Ellen J Hahn, Mary Kay Rayens, Kenneth L Kirsh, et al.
Journal of Behavioral Medicine
|
September 13, 2012
Attentional bias for prescription opioid cues among opioid dependent chronic pain patients
Eric L Garland, Brett E Froeliger, Steven D Passik, et al.
Journal of Opioid Management
|
March 10, 2015
Specimen validity testing in urine drug monitoring of medications and illicit drugs: clinical implications
Kenneth L Kirsh, Paul J Christo, Howard Heit, et al.
Palliative & Supportive Care
|
April 6, 2006
An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients
Dale E Theobald, Kenneth L Kirsh, Elizabeth Holtsclaw, et al.
Journal of Pain and Symptom Management
|
May 15, 2002
An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms
Dale E Theobald, Kenneth L Kirsh, Elizabeth Holtsclaw, et al.
Journal of Addiction Medicine
|
September 4, 2015
A Survey of ASAM Members' Knowledge, Attitudes, and Practices in Urine Drug Testing
Kenneth L Kirsh, Louis E Baxter, Adam Rzetelny, et al.
Page
of 12